12:00 AM
 | 
Apr 11, 2011
 |  BC Week In Review  |  Company News  |  Deals

IS Pharma, Sinclair deal

The boards of both companies agreed to merge and form Sinclair IS Pharma plc. The newco, which will be headquartered in the U.K., will focus on developing therapies for dermatology, cancer, critical care and wound care. IS Pharma shareholders will receive 2.7 new Sinclair shares for each IS Pharma share held. Following...

Read the full 247 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >